Skip to main content
EuBiologics Co., Ltd. logo

EuBiologics Co., Ltd. — Investor Relations & Filings

Ticker · 206650 ISIN · KR7206650004 KO Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2021-08-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 206650

About EuBiologics Co., Ltd.

http://eubiologics.com/eng/

EuBiologics Co., Ltd. is a biopharmaceutical company focused on improving global public health through the development and supply of safe and effective vaccines. The company specializes in preventative vaccines against global pandemics and emerging infectious diseases, with a key product being its oral cholera vaccine. In addition to its vaccine pipeline, EuBiologics provides Contract Research and Manufacturing Organization (CRMO) services. These services cover the development and GMP-compliant production of mammalian cell and microbial-derived biopharmaceuticals, including protein-based therapeutics and antibodies. The company is committed to technological innovation and adhering to international standards to address global health challenges.

Recent filings

Filing Released Lang Actions
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'EuBiologics Co., Ltd.' covering the period from January 1, 2021, to June 30, 2021. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-13 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (a virtual conference for institutional investors). It provides details such as the date, purpose, and method of the meeting, and mentions that IR materials will be posted later. Since it is an announcement of an event rather than the presentation itself, and it is under 5,000 characters, it falls under the category of a Regulatory Filing (RNS) or a general announcement of company activity.
2021-08-13 Korean
파생상품거래손실발생
Capital/Financing Update Classification · 100% confidence The document is a regulatory disclosure from Eubiologics regarding a 'Loss from Derivative Transactions' (파생상품거래손실발생). It details the nature of the loss (valuation loss on derivative financial liabilities related to bonds with warrants), the financial impact relative to equity, and the cause. Since this is a specific regulatory disclosure of a material financial event that does not fit into categories like earnings releases, annual reports, or management changes, it falls under the general regulatory filing category.
2021-08-13 Korean
불성실공시법인지정(공시불이행 2건)
Regulatory Filings Classification · 95% confidence The document is an official regulatory notice regarding the designation of Eubiologics as an 'unfaithful disclosure corporation' (불성실공시법인) due to delayed disclosures. This is a regulatory announcement concerning compliance and penalties, which falls under the category of Regulatory Filings (RNS) as it does not fit into specific categories like legal proceedings or financial reports.
2021-08-09 Korean
[기재정정]신규시설투자등
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Eubiologics regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to the investment timeline (end date) due to equipment delivery delays. This type of disclosure regarding capital expenditure and facility investment updates falls under general regulatory filings as it does not fit into specific categories like M&A, dividends, or share repurchases.
2021-07-30 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korean Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details changes to contract dates and terms due to COVID-19. Since this is a specific regulatory disclosure regarding a material contract update and does not fit into categories like financial reports, board changes, or shareholder meetings, it falls under the 'Regulatory Filings' (RNS) category.
2021-07-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.